Search research articles
Contact Us
Filters
Showing results (71-80 of 192) with videos related to
Page
of 20
Sort By:
Journal of Medicinal Chemistry
|
May 22, 2025
A "Ligand First" Approach toward Selective, Covalent JNK2/3 Inhibitors
Valentin R Wydra, Nicole Plank, Stefan Zwirner, et al.
World Journal of Gastroenterology
|
March 9, 2005
Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver
Timm Kirchhoff, Lars Zender, Sonja Merkesdal, et al.
Nature Cell Biology
|
August 1, 2017
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Selene Glück, Baptiste Guey, Muhammet Fatih Gulen, et al.
European Journal of Medicinal Chemistry
|
March 24, 2022
Development of novel urea-based ATM kinase inhibitors with subnanomolar cellular potency and high kinome selectivity
Teodor Dimitrov, Cetin Anli, Athina Anastasia Moschopoulou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 31, 2009
Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues
Florian Kühnel, Engin Gürlevik, Thomas C Wirth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 4, 2026
Targeting of p53-Transcriptional Dysfunction by Conditionally Replicating Adenovirus Is Not Limited by p53-Homologues
Florian Kühnel, Engin Gürlevik, Thomas C Wirth, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 20, 2024
Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in <i>KRAS</i>-mutant cancers
Robin A Jansen, Sara Mainardi, Matheus Henrique Dias, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report
Raphaela D Lewetag, Katharina Kluthe, Nils F Trautwein, et al.
Frontiers in Endocrinology
|
January 23, 2024
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
Martina Hinterleitner, Ruben Pfeiffer, Nils F Trautwein, et al.
Frontiers in Oncology
|
April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Clemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 192) with videos related to
Sort By:
Page
of 20
Journal of Medicinal Chemistry
|
May 22, 2025
A "Ligand First" Approach toward Selective, Covalent JNK2/3 Inhibitors
Valentin R Wydra, Nicole Plank, Stefan Zwirner, et al.
World Journal of Gastroenterology
|
March 9, 2005
Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver
Timm Kirchhoff, Lars Zender, Sonja Merkesdal, et al.
Nature Cell Biology
|
August 1, 2017
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Selene Glück, Baptiste Guey, Muhammet Fatih Gulen, et al.
European Journal of Medicinal Chemistry
|
March 24, 2022
Development of novel urea-based ATM kinase inhibitors with subnanomolar cellular potency and high kinome selectivity
Teodor Dimitrov, Cetin Anli, Athina Anastasia Moschopoulou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 31, 2009
Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues
Florian Kühnel, Engin Gürlevik, Thomas C Wirth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 4, 2026
Targeting of p53-Transcriptional Dysfunction by Conditionally Replicating Adenovirus Is Not Limited by p53-Homologues
Florian Kühnel, Engin Gürlevik, Thomas C Wirth, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 20, 2024
Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in <i>KRAS</i>-mutant cancers
Robin A Jansen, Sara Mainardi, Matheus Henrique Dias, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report
Raphaela D Lewetag, Katharina Kluthe, Nils F Trautwein, et al.
Frontiers in Endocrinology
|
January 23, 2024
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
Martina Hinterleitner, Ruben Pfeiffer, Nils F Trautwein, et al.
Frontiers in Oncology
|
April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
Clemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Page
of 20